Enter your login e-mail to the account
Search
- The first symptoms of multiple sclerosis and the importance of early treatment
Doc. MUDr. Vladimír Donáth, PhD.
(5/2017, Interdisciplinary consilium ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(2/2017, Interdisciplinary consilium ) - Possibilities for early detection of patients with the diagnosis of MS in general practitioner
prof. MUDr. Egon Kurča, PhD., MUDr. Natália Jankovičová,
(3/2016, Interdisciplinary consilium ) - Sclerosis multiplex – informácie pre prax
doc. MUDr. Eleonóra Klímová, CSc.
(5/2006, Consilium )
- Multiple sclerosis – psychoneuroimmunological disease of the central nervous system
doc. MUDr. Eva Havrdová, CSc., MUDr. Eva Krasulová, Mgr. Jana Blahová Dušánková
(3/2009, Review articles )
- Therapeutic advances in hereditary muscular disorders
MUDr. Stanislav Voháňka, CSc., MBA
(3/2011, Review articles ) - Link atrophy and disability in multiple sclerosis
MUDr. Jiří Piťha
(3/2014, Review articles ) - Glatiramer acetate: long-term immunomodulatory therapy in multiple sclerosis – safety, efficacy, adherence and persistence assesment
MUDr. Olga Zapletalová
(2/2016, Review articles ) - Migraine and multiple sclerosis
MUDr. Rudolf Kotas, Ph.D., MUDr. Marta Vachová
(6/2023, Review articles ) - The individual preferences in choice of suitable MS treatment therapy
MUDr. Marta Vachová
(6/2014, Review articles ) - Fingolimod in clinical practice: case reports
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(6/2014, Case reports ) - Multiple sclerosis in patients of adolescent age
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová
(3/2013, Review articles ) - Recent advances in treatment of multiple sclerosis with interferon beta in Czech Republic?
MUDr. Michal Dufek
(1/2011, Review articles ) - Porovnanie bezpečnosti a monitoringu DMD liekov prvej eskalačnej línie – dimetylfumarát, fingolimod, kladribin a okrelizumab
MUDr. Eva Kmeťová
(6/2018, Review articles ) - Orphan drugs in treatment of rare neuromuscular disorders
doc. MUDr. Peter Špalek, PhD.
(2/2021, Main topic ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - Current options in the treatment of multiple sclerosis
MUDr. Eva Meluzínová
(5/2010, Review articles ) - Nové možnosti léčby vrozených neuromuskulárních onemocnění v dětském věku
MUDr. Jana Haberlová, Ph.D.
(2/2018, Main topic ) - Multiple sclerosis and the menopause
doc. MUDr. Peter Koliba, CSc.
(4/2011, From the boundary of neurology ) - Výskyt deprese u roztroušené sklerózy
Prof. MUDr. Ivana Štětkářová, CSc., PhDr. Alena Javůrková, Ph.D., PhDr. Jaroslava Raudenská, Ph.D.
(2/2018, Review articles ) - The incidence, prevention and treatment of decrease BMD and fractures in patients with Duchenne muscular dystrophy
MUDr. Ondřej Souček, Ph.D.
(4/2014, From the boundary of neurology ) - Escalation therapy in multiple sclerosis
MUDr. Pavel Ryška, Ph.D., doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek
(6/2016, Case reports ) - Long-term data of multiple sclerosis treatment with ocrelizumab – eficacy, safety and clinical experience
MUDr. Mgr. Matouš Rous, MUDr. Zuzana Rous, Ph.D.
(6/2021, Review articles ) - Treatment of multiple sclerosis in Czech Republic – options and reality
MUDr. Michal Dufek
(1/2014, Review articles ) - Adherence to treatment in multiple sclerosis
MUDr. Pavel Hradílek, Ph.D.
(3/2012, Review articles ) - Súčasné možnosti dlhodobej liečby roztrúsenej sklerózy: výhody a nevýhody perorálnej liečby roztrúsenej sklerózy
MUDr. Zuzana Matejčíková, Ph.D.
(3/2018, Review articles ) - Multiple sclerosis (MS) is autoimmune disorder affecting the central nervous system
MUDr. Miriam Fedičová, MUDr. Marianna Vitková, PhD. , doc. MUDr. Jarmila Szilasiová, PhD., prof. MUDr. Zuzana Gdovinová, CSc., FESO, FEAN
(3/2020, Review articles ) - Treatment with interferon beta despite persistent elevation of liver enzymes
MUDr. Magdaléna Hladíková, Ph.D., MUDr. Petra Praksová, Ph.D., MUDr. Hana Dujsíková, Ph.D.
(4/2015, Case reports ) - Glatiramer acetate and treatment of multiple sclerosis
doc. MUDr. Radomír Taláb, CSc., MUDr. Marika Talábová, MUDr. Ludovít Hofmann Klzo, Ph.D.
(4/2015, Case reports ) - Alemtuzumab in multiple sclerosis treatment
MUDr. Eva Meluzínová
(4/2015, Pharmacotherapy ) - Improving gait in patients with multiple sclerosis
Mgr. Klára Novotná, Ph.D., MUDr. Jana Lízrová Preiningerová
(3/2022, From the boundary of neurology ) - New perspective treatment of multiple sclerosis
doc. MUDr. Vladimír Donáth, CSc., MUDr. Silvia Laurincová
(2/2014, Main topic ) - Primary progressive multiple sclerosis – diagnosis, clinical aspects and treatment
MUDr. Ladislav Gurčík, PhD.
(5/2011, Review articles ) - Strategy initiation of treatment for multiple sclerosis
MUDr. Jiří Piťha
(4/2016, Review articles ) - Multiple sclerosis and pregnancy – first line treatment and escalation therapy
MUDr. Simona Halúsková, doc. MUDr. Martin Vališ, Ph.D.
(6/2019, Review articles ) - Palliative care in advanced muscular dystrophies
MUDr. Jan Hromada
(1/2010, Main topic ) - Léčba relaps-remitentní roztroušené sklerózy mozkomíšní
doc. MUDr. Eva Havrdová, CSc., MUDr. Eva Krasulová
(4/2008, Main topic ) - New ways of administering injection drugs in relapsing multiple sclerosis
MUDr. Jiří Piťha
(5/2015, Review articles ) - Clinical experiences in multiple sclerosis patients treated with alemtuzumab
MUDr. Mária Ďurišová, MUDr. Eva Recmanová
(2/2020, Case reports ) - Correlation between magnetic resonance imaging and clinical disability in multiple sclerosis
prof. MUDr. Zdeněk Seidl, CSc., doc. MUDr. Manuela Vaněčková, Ph.D.
(5/2014, Review articles ) - Does the development of new drugs for multiple sclerosis change the prognosis of the patient?
prof. MUDr. Eva Havrdová, CSc.
(3/2011, Review articles ) - VIII. neuromuskulárny kongres s medzinárodnou účasťou, 16. – 17. apríl 2015, Bratislava XVI. konferencia o neuromuskulárnych ochoreniach
doc. MUDr. Peter Špalek, PhD.
(2/2015, Events )
- Prevention of vitamin K deficiency bleeding in newborns and young infants
MUDr. Milan Hanzl, Ph.D.
(1/2011, Focus ) - Organizácia muskulárnych dystrofikov v SR
(1/2011, Focus )
- Cutaneous complications of the 1. line immunomodulators in the Multiple Sclerosis treatment
doc. MUDr. Eleonóra Klímová, CSc., MUDr. Adrián Ryník, MUDr. Monika Daňová, PhDr. Andrea Lengyelová
(1/2013, Interdisciplinary consilium )












